The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Dechert LLP

ONE INTERNATIONAL PLACE, 40TH FLOOR, 100 OLIVER STREET, BOSTON, MA 02110-2605, USA
Tel:
Work +1 617 728 7100
Fax:
Fax +1 617 426 6567
Email:
Web:
www.dechert.com

Thomas J Friedmann

Tel:
Work +1 617 728 7120
Email:
Dechert LLP

Work Department

Corporate

Career

Thomas J. Friedmann, co-chair of Dechert’s Global Corporate Finance and Capital Markets Practice, represents domestic and foreign issuers and investment banks in public and private securities transactions. Mr. Friedmann also advises corporate clients on matters relating to securities law, corporate governance, and general corporate matters, including financial restructuring and securitization transactions.

Education

Harvard College, A.B., 1985, magna cum laude; University of Virginia Darden School of Business, MBA, 1991; University of Virginia, J.D., 1991


United States: Finance

Capital markets: debt offerings

Within: Capital markets: debt offerings

Dechert LLP has an active debt practice, which stands out for its niche expertise in life sciences and permanent capital vehicles, especially business development companies. In a recent example of its work in this area, Philadelphia-based partners Kenneth Young and Gregory Schernecke advised business development company Corporate Capital Trust on a private offering of $140m of senior notes. Boston-based corporate finance specialist Thomas Friedmann co-chairs the capital markets group and assisted Eagle Point Credit Company with several recent deals, including handling its $31.6m public notes offering. David Rosenthal co-chairs the department from New York.

[back to top]

Capital markets: equity offerings

Within: Capital markets: equity offerings

At Dechert LLP, Boston-based group co-head Thomas Friedmann is well known for his specialist skill set in acting for business development companies. In a recent example, Friedmann advised Eagle Point Credit on its $30.3m public offering. The firm is also active on behalf of underwriters, with Philadelphia-based partners James Lebovitz and Gregory Schernecke advising the underwriters on Amicus Therapeutics’ $258.8m public offering. David Rosenthal co-leads the practice from New York and with Schernecke acted for the joint book-running managers on Inovio Pharmaceuticals’ $75m public offering. Other key clients include Franklin Square Capital Partners, Golub Capital and Stifel Nicolaus.

[back to top]

Capital markets: high-yield debt offerings

Within: Capital markets: high-yield debt offerings

Dechert LLP houses a robust issuer-side practice, which has specialist expertise in advising life sciences companies and permanent capital vehicles. Boston-based Thomas Friedmann co-heads the department and led advice to Eagle Point Credit Company on several deals over the past year, including on its $31.6m notes offering. Stephen Leitzell - who is a key name in Philadelphia - advised B&G Foods on a $500m notes offering. New York’s David Rosenthal co-chairs a team that also includes James Lebovitz and newly made-up partner Gregory Schernecke - both of whom operate from Philadelphia.

[back to top]

Financial services regulation

Within: Financial services regulation

Noted for its ‘excellent technical knowledge and relationships with the regulators’, Dechert LLP provides ‘thorough and accurate’ advice across a range of regulatory matters for clients including Melrose Credit Union, Interactive Brokers Group and Independent Community Bankers of America. The team is perhaps best-known for its work on behalf of asset management clients, both on discrete regulatory issues as well as regulatory driven transactional activity. The excellent’ Thomas Vartanian has vast knowledge of the Dodd-Frank Act and is noted for his expertise at guiding clients through the intricacies of the Volcker Rule, both in terms of ensuring that existing activities and operations are compliant with it, as well as its impact on hedge and private equity funds on investments in and acquisitions of financial institutions and bank holding companies. Boston-based Thomas Friedmann has niche expertise advising on the regulatory issues impacting on business development companies; he was recently involved in the firm’s work for CION Investment Corporation on its $277m acquisition of Credit Suisse’s business development company. Senior counsel David Ansell is regularly involved in financial services M&A and, alongside counsel Robert Ledig, recently provided regulatory input for ECN Capital on the $1.25bn sale of its US commercial and vendor finance business to PNC Bank. David Harris is also recommended.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to